跳至主要内容
临床试验/CTRI/2014/09/005061
CTRI/2014/09/005061招募中1 期

A study of safety, efficacy and refractive outcomes of MEL 90 excimer laser platform - MEL 90

ETHRADHAMA SUPERSPECIALITY EYE HOSPITA0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Any gender, 21 to 40 years of age
  • Stable corneal conditions within the last 12 months
  • Stable refraction since past 12 months ( <0.5D change within past 12 months)
  • Healthy ocular surface with stable tear film
  • Discontinuation of Soft contact lenses 1 week, and rigid contact lenses 3 weeks prior to surgery
  • For myopia correction, myopia upto -10 Diopters
  • For hyperopia correction, hyperopia upto + 3 Diopters
  • For astigmatic correction, astigmatism upto 3 Diopters

排除标准

  • Thin corneas (Corneal pachymetry <480u)
  • Steep corneas Kmax >48 D
  • Keratoconus suspects or frank keratoconus
  • Moderate to severe dry eye (Shirmers1 <10 mm)
  • Socket / globe /lid anomalies â?? very deep set eyes, nanophthalmos
  • Severe meibomian gland disease, lid abnormalities
  • Severe atopy
  • Contact lens overuse
  • Pregnant and nursing mother
  • Autoimmune disorders
  • Pts on systemic medications eg Iso retinoic acid, hormonal preperations, OCPs, antidepressants.

研究者

发起方
ETHRADHAMA SUPERSPECIALITY EYE HOSPITA

相似试验